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Abstract
The issue of open disclosure has received growing attention from policy-makers, legal experts and academic researchers, pre-
dominantly in a number of English-speaking countries. While implementing open disclosure in practice is still an on-going
process, open disclosure now forms an integral part of health policy in various American states, the UK, Canada, Australia and
New Zealand, with a number of measures having been put in place to encourage open disclosure and to mitigate some of the
barriers to such open communication. In contrast, this issue has received little attention in non-English-speaking countries and
there is currently no empirical data relating to actual practice or practitioners’ attitudes and views in most countries in continen-
tal Europe. This article critically examines Germany’s current approach to open disclosure. It ﬁnds that the issue plays no signiﬁ-
cant role in German health policy with very limited measures explicitly concerning such communication currently in place.
While a number of aspects of the wider regulatory framework appear to be supportive, Germany is still in the early stages of a
systematic approach and additional measures are required to further promote open disclosure within the self-governing German
healthcare system. This exploration provides an example of a non-English-speaking country’s approach to open disclosure and
may be of particular interest to neighbouring German-speaking and civil law countries such as Switzerland and Austria.
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Open disclosure is the prompt, compassionate and honest
communication with patients and families following a health-
care incident that has resulted in harm [1–3]. While the
open disclosure process can vary, it typically includes an
acknowledgment; an expression of regret or an apology; an
investigation into the incident; providing a factual explanation
of what happened and explaining the steps being taken to
manage the incident and prevent recurrence [1, 2]. The issue
has received growing attention from policy-makers, legal
experts and academic researchers, predominantly in a
number of English-speaking countries.
The development of open disclosure
The practice of maintaining ‘a humanistic, care-giving attitude
with those who had been harmed, rather than respond[ing] in
a defensive and adversarial manner’ was ﬁrst articulated at
Montreal Hospital [4]. Soon after this in 1989, Dr Steve
Kraman, faced with a highly litigious environment and rising
legal costs, began openly sharing incident information at the
Veteran Affairs Hospital in Lexington. This approach not only
led to a signiﬁcant reduction in complaints and legal costs, but
has improved collaboration within the healthcare relationship
[5, 6]. Similarly, Richard Boothman et al. [7] have achieved im-
pressive results with disclosure in a very challenging legal en-
vironment at the University of Michigan.
The disclosure of healthcare incidents, however, has evolved
over the past two decades from a strategic response to rising
legal costs focusing on organizational risk minimization, to an
ethical practice seeking to re-establish trust by meeting patients’
needs and expectations following an incident and to improve
the quality of care. The Massachusetts Coalition for the
Prevention of Medical Errors’ 2006 document ‘When Things
Go Wrong’, for instance, was explicit in privileging ethical con-
siderations over legal, ﬁnancial and reputational issues [3].
Barriers to open disclosure
There is, however, currently a large divergence between
patients’ preferences to be told about healthcare errors and
current practice. While health practitioners typically endorse
disclosure in principle, they often do not share information
International Journal for Quality in Health Care vol. 24 no. 1
# The Author 2011. Published by Oxford University Press in association with the International Society for Quality in Health Care;
all rights reserved 23
International Journal for Quality in Health Care 2012; Volume 24, Number 1: pp. 23–27 10.1093/intqhc/mzr073
Advance Access Publication: 2 December 2011
in practice, with studies suggesting that as few as 30% of
harmful errors are disclosed to patients [8].
The most often cited barrier to open and honest commu-
nication following an incident is the fear of legal liability—
that communication may lead to a lawsuit against them, a
lack of legal protection when providing information and
apologies and the potential loss of liability insurance if they
say too much or the wrong thing [8, 9].
Legal concerns, however, are not the only factor that may
lead practitioners not to disclose incidents. Indeed, such con-
cerns can often disguise deeper emotional fears. John Banja,
for instance, has argued that a harm-causing error can be
such an assault to the practitioner’s sense of competency and
adequacy that various protective, self-regarding and defensive
psychological responses can be triggered which can often
lead to open communication being avoided altogether or
conducted inadequately [9].
Regulating open disclosure
Open disclosure now forms an integral part of health legisla-
tion and policy in a number of English-speaking countries,
with various measures having been put in place to encourage
disclosure and mitigate some of the barriers to such commu-
nication—a reﬂection also of the increasing focus on the
systems approach to errors in healthcare [10].
Governmental and organizational standards and policies
have been developed to promote a clear and consistent
approach to open disclosure in various American states [11],
the UK [1], Canada [12], Australia [2] and New Zealand
[13]. A number of American states have also implemented
speciﬁc ‘disclosure laws’ which mandate disclosure in certain
circumstances and ‘apology laws’ to protect the communica-
tion from being used in a legal action as proof of the
practitioner’s negligence [14]. In addition, professional orga-
nizations’ ethics standards in these countries often explicitly
endorse open disclosure [9].
Such measures are, of course, no panacea; there remains a
challenge of translating statements of principle into practice,
which is an on-going process in these countries. However,
such interventions can play an important role in inﬂuencing
professional, national and organizational cultures, which have
a signiﬁcant effect on the practice, values and individual atti-
tudes in a workplace. While these cultures are dynamic, they
also have considerable inertia which requires both strong
interventions and time to change [15].
Indeed, research in these English-speaking countries suggests
that these measures are making a difference. Rick Iedema et al.
[16] in Australia, for instance, have found that the disclosure of
incidents is becoming more frequent and that one of the
driving forces behind this change has been state and health pro-
vider policies, along with the increase in specially trained staff.
Open disclosure in Germany
In contrast to the English-speaking countries described
above, the issue of open disclosure currently plays no
signiﬁcant role in German health policy. While the import-
ance of reporting incidents as part of quality improvement
programmes has been recognized, lacking from the ongoing
discussion has been the emphasis of the needs of patients in
such situations. Although there was a factorial survey of the
general public regarding medical errors in 2004 [17], there is
currently no empirical data relating to patients’ or practi-
tioners’ attitudes and views regarding open disclosure, and
very little is known about current practice. Indeed, open
disclosure has not yet received a lot of attention in
non-English-speaking countries in general. There is, for in-
stance, currently no empirical data relating to actual practice
or patients’ and practitioners’ attitudes and views in most
countries in continental Europe.
Wider context
Before examining open disclosure in Germany, it is helpful
to have an understanding of the wider context in which this
discussion is situated.
While commentators agree that a US-style malpractice
crisis has not occurred in Germany, and is unlikely to do so,
the increase in malpractice litigation is an issue of concern
[18]. The increase in litigation began reasonably early in
Germany, with 6000 claims a year already being made by
the end of the 1970s (compared with the 500 claims a year
in England estimated by the Pearson report in the
mid-1970s). The current ﬁgure is estimated to be around
20 000–35 000 (a recent study suggests around 6000 claims
a year are made in England). The average cost of claims in
Germany, including those settled or abandoned, also trebled
between 1981 and 2001, and in some specialities such as
gynaecology the increase has been six-fold [18]. The asso-
ciated increase in liability insurance premiums for health pro-
fessionals has received growing attention [19].
It was in response to the increase in malpractice cases and
a growing climate of distrust between doctors and patients
that had emerged, that led to the Expert Commissions
and Arbitration Boards (Gutachterkommissionen und
Schlichtungsstellen) being established in 1975 by the State
Medical Associations (Landesa¨rztekammern). This process pro-
vides free expert appraisal and extrajudicial conciliation
where all parties consent to proceedings. The use of this
mechanism has steadily increased over time, with a quarter
of all suspected cases of medical liability now being assessed
by the Expert Commissions and Arbitration Boards, and
their non-binding decisions enjoy high acceptance rates
(90% of all cases settled) [20]. While data from the Expert
Commissions and Arbitration Boards are pooled in the na-
tional Medical Error Reporting System for systematic learn-
ing, the adversarial proceedings themselves are focused on
establishing whether or not there is a medical error for
which the practitioner is liable to pay compensation.
It also appears that many German hospitals are currently
not taking a systematic approach to medical errors. In 2010,
the University of Bonn’s Institute for Patient Safety con-
ducted the ﬁrst detailed national survey concerning the im-
plementation status of clinical risk management in German
McLennan et al.
24
hospitals. The survey was sent to all 1820 German hospitals
with 50 beds or more and had a total of 484 respondents.
The results showed that clinical risk management and issues
of patient safety were an integral part of the agendas for the
meetings of the hospital management in only 39% of
respondents and staff were regularly offered training in
clinical risk management in only 25% of respondents [21].
Current measures
There are currently very limited measures explicitly concern-
ing open disclosure in place in Germany. There are no gov-
ernmental (federal or state) laws or policies relating to open
disclosure. It also appears that the majority of German
healthcare organizations do not have any internal standards
concerning communication with patients and families follow-
ing an error. The survey conducted by the University of
Bonn included a question asking whether there is an internal
hospital standard which ensures that patients or their rela-
tives are informed of serious medical errors resulting in
damage promptly and receive an offer of support. Only 22%
of respondents currently have such a standard; 21% have no
standard but plan to develop one and the remaining 57%
have no standard and have no plans to develop one [21].
There is also currently no mention of open disclosure in
the Federal Medical Association’s (Bundesa¨rztekammer)
(Model) Professional Code of Conduct, nor in the derived
Professional Codes of Conduct of the State Medical
Associations (Landesa¨rztekammern).
Thomeczek et al. [22] have argued, however, that the wider
legal framework that exists in Germany is generally support-
ive of communication with the patient after an incident.
Indeed, unlike the situation in most English-speaking coun-
tries, the healthcare relationship under German law is almost
invariably a contractual one [18], and the treatment contract
places obligations on healthcare providers to inform patients
of incidents and complications during the course of treat-
ment. However, the predominant view is that there is no
legal obligation on the doctor to inform the patient that they
were at fault for the incident or complication [22].
In 2008, section 105 of the Insurance Contract Law Act
(Versicherungsvertragsgesetz) was added to provide that insurance
agreements that include ‘non-cooperation’ clauses, which
releases the insurance company from its obligation to pay
costs if liability is admitted without prior consent, are now
invalid.
In principle, practitioners are now free to speak to patients
about the incident, give them a report of the facts and
express regret, and may also accept liability without losing
their insurance cover [22]. However, if the practitioner
accepts liability for an incident, they may have to prove to
their liability insurer that this claim was valid to be covered.
Legal commentaries therefore recommend that practitioners
do not rely on section 105 without speaking to their insur-
ance company prior to disclosing incidents to patients [23].
Unfortunately, it appears there is currently no consistent
approach to this dilemma by the liability insurers, therefore
denying practitioners legal security.
The legal dilemma is exempliﬁed in a brochure for practi-
tioners by the German Medical Insurance (Deutsche
A¨rzteversicherung) that is entitled ‘Tips for proper behaviour in
a liability claim’ [24]. While the publication encourages practi-
tioners to speak to the patient as soon as possible following
an incident, to take the patient’s concerns seriously and to be
empathic and compassionate, it also cautions the practitioner
not to accept any liability, as this could risk their insurance
cover.
A positive step forward, however, has been the recent
publication by the German Coalition for Patient Safety of a
brochure entitled ‘Reden ist Gold’, a play on the German
saying ‘Talk is silver, silence is golden’ (Reden ist Silber,
Schweigen ist Gold). The Coalition for Patient Safety
(Aktionsbu¨ndnis Patientensicherheit) (www.aktionsbuendnis-
patientensicherheit.de) is a non-proﬁt organization formed in
April 2005 by health professionals, their associations and
patient organizations to build a common platform to
improve patient safety in Germany.
Rather than following its counterparts in Switzerland and
Austria, which have translated the ‘Massachusetts Coalition
for the Prevention of Medical Errors’ ‘When Things Go
Wrong’ into German, the Coalition for Patient Safety wanted
a more practical guide for practitioners in the German
context, which includes an outline of the legal situation sur-
rounding such communication. This is intended to provide
practitioners with greater clariﬁcation and will hopefully lead
to this issue receiving more attention in the German health
system.
It should be noted, however, that the Swiss Patient
Safety Foundation (Stiftung fu¨r Patientensicherheit) (www.
patientensicherheit.ch) offers interactive and practical
oriented workshops concerning communication with patients
and families after an incident, something that is not currently
available in Germany.
Further possible measures
While a number of aspects of the wider legal framework cur-
rently in place in Germany are supportive of open disclosure
and the Coalition for Patient Safety’s brochure is a positive
step forward, Germany is still in the early stages of a system-
atic approach and additional measures are required to further
promote open disclosure.
The need for strong interventions is arguably more im-
portant in Germany as it is ( just like its German-speaking
neighbours) seen to be a high ‘uncertainty avoidance (UA)’
country. As Helmreich and Merritt [15] note, the need for
rules in a high UA country is seen as an emotional need to
resolve ambiguity quickly and leave as little as possible to
chance, and that discomfort over uncertainty can lead to
either ‘strict adherence to ineffectual rules (rules for rules’
sake) or hasty, unreasoned action aimed at alleviating the
emotional discomfort associated with the uncertainty’. Thus,
in the absence of clear guidance and more legal certainty in
relation to the communication of healthcare incidents to
patients in Germany, it appears very unlikely that the
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attitudes and behaviours of practitioners will change towards
more transparency and openness.
It is, however, helpful to put any possible measures in the
context of the wider theoretical framework for quality assur-
ance that exists in Germany, which is consistent with the
logic of the German social market economy. While health
policy set by the Federal Ministry of Health establishes the
legal regulatory framework in Germany, the regulatory details
are generally set by corporatist bodies in the self-governing
German healthcare system [25]. It is, therefore, very improb-
able that we will see in Germany the kind of national
and state standards and laws introduced in some English-
speaking countries.
Federal Medical Association. The Federal Medical Association
(Bundesa¨rztekammer) (www.bundesaerztekammer.de) is the
umbrella organization of medical self-government in
Germany and represents the professional interests of
German doctors. As a working group of the 17 State
Medical Associations (Landesa¨rztekammern) the Federal
Medical Association is not a public body itself, but an
unincorporated association. The German Medical Assembly
(Deutscher A¨rztetag) is the annual general meeting of the
Federal Medical Association and acts as the ‘parliament of
the medical profession’, including delegates from all the State
Medical Associations. The German Medical Assembly’s tasks
include setting nationwide regulations and articulating and
adopting positions of health policy. Given the important role
medical self-government has in Germany, the German
Medical Assembly adopting a position in support of open
disclosure would be highly inﬂuential. Such a position could
be supported by the inclusion of open disclosure in the
Federal (Model) Professional Code of Conduct, and the
respective Codes of Conduct at the State level.
Statutory Health Insurance. Statutory Health Insurance
(gesetzliche Krankenversicherung) is one of the ﬁve pillars of the
German social security system under which 90% of the
population is insured. The National Association of Statutory
Health Insurance Funds, together with the National
Association of Statutory Health Insurance Physicians, the
National Association of Statutory Health Insurance Dentists
and the German Hospital Federation forms the Federal Joint
Committee (Gemeinsame Bundesausschuss; www.g-ba.de). The
Federal Joint Committee was established on 1 January 2004
by the Statutory Health Insurance Modernisation Act and in
addition to deciding which beneﬁts are to be included in the
statutory health insurance catalogue, it has the duty to ensure
quality in statutory health insurance accredited facilities and
decides quality assurance measures for outpatient and
inpatient health care. Since 1 July 2008 following health
reforms, the Federal Joint Committee has made all decisions
in a single cross-sectoral decision-making body capacity. By
developing directives or guidelines that speciﬁcally include
open disclosure as part of quality assurance, the Federal Joint
Committee could set the framework for a broader
implementation of open disclosure in the German health
system.
Federal Ministry of Health. The Federal Ministry of Health is
responsible not only for maintaining and enhancing the
quality of the healthcare system in Germany, but for also
strengthening the interests of patients. Situated within
the Federal Ministry of Health, is the Patient Commissioner
of the Federal Government (Patientenbeauftragter der
Bundesregierung), currently Wolfgang Zo¨ller. The Ofﬁce of the
Commissioner (www.patientenbeauftragter.de) was
established on 1 January 2004 by the Statutory Health Insurance
Modernisation Act to support the development of patient
rights and publically advocate for patients’ interests;
particularly in relation to the right to information. Given the
potential important role of open disclosure in quality
improvement, respecting patient rights and reducing errors
from escalating into formal complaints or lawsuits, the
Patient Commissioner should be advocating open disclosure.
A ﬁrst step would be to explicitly recognize the patients’
right to be informed about incidents and errors that occur in
their treatment. A new patients’ rights law currently being
drafted by the Patient Commissioner could potentially
provide an appropriate framework for this. An additional
measure would be for the Patient Commissioner to lobby for
legislative changes that would address the current legal
dilemma for health practitioners in relation to accepting
responsibility for healthcare errors.
Summary
Although the ethical, ﬁnancial and quality improvement
beneﬁts of open disclosure have been shown in the
English-speaking world, Germany still needs to provide a
more supportive and consistent framework that allows practi-
tioner to safely disclose incidents to patients. Without clear
guidance and a consistent framework that is supportive of
open disclosure, it seems unlikely that the attitudes and beha-
viours of practitioners will change towards more transparency
and openness.
How this could be achieved within the unique structure
of the German health system has been outlined in this
article. Given the important role of medical self-
government has in Germany, it is important that the
Federal Medical Association show leadership on this issue.
The adoption of a position in support of open disclosure
by the German Medical Assembly would be highly inﬂuen-
tial. The Federal Joint Committee could also help set the
framework for a broader implementation by developing
directives or guidelines. Finally, explicitly recognizing the
patients’ rights to be informed about incidents and errors
that occur in their treatment in the new patients’ right law
currently being developed by the Patient Commissioner of
the Federal Government may help open disclosure receive
more attention.
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